InvestorsHub Logo
Followers 16
Posts 1062
Boards Moderated 0
Alias Born 09/01/2019

Re: Money $hot post# 13854

Tuesday, 02/23/2021 9:19:21 PM

Tuesday, February 23, 2021 9:19:21 PM

Post# of 16703
I would hope the benefits of Ifenprodil that may be shown with the COVID Trial and then the supplemental lung scaring X rays / etc, may make some outcome points common and overlapping with IPF/ARDS/CC for the Phase 3. IDKS but hope they have some plan.
We're piss-ants. I hope Novatech isn't getting full pay for the failures in SK and now in Australia.
4838 patients X $25k = $121M. BP money. IPF was our Ifenprodil 'FDA Orphan drug' path before COVID. We beat Merck by 40%..GLTA...